Definitive Contract 75N93019C00067
Award Date 9/30/19
Potential Completion Date 9/29/24
Potential Value $4.5M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
La Jolla, CA 92037, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
13
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $4,495,633 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the La Jolla Institute for Immunology, a non-profit research institute, for "LARGE SCALE T CELL EPITOPE DISCOVERY". The contract has no set-aside designation. The contract involves T cell and B cell immunology research, including epitope identification, vaccine development, and studies on the immune mechanisms underlying infectious diseases, allergies, autoimmune...
- This is a $5,455,392.00 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the La Jolla Institute for Immunology, a non-profit research institute. The contract is for the identification and validation of epitopes (immune system targets) that are conserved across viral pathogen families with pandemic potential. The research will focus on infectious diseases, autoimmune diseases, and transplant rejection. No set-aside was used for this award. The...
- This federal contract award from the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, is for $7,346,666.00 to the La Jolla Institute for Immunology (LJI), a non-profit research institute, to conduct large-scale T cell epitope discovery. The contract has no set-aside designation and is a definitive contract with a cost-no-fee pricing type, with a completion date of September 29, 2024. LJI will collaborate with...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID) to the La Jolla Institute for Immunology (LJI), a non-profit research institute. The $6,153,015 definitive contract, awarded on March 31, 2004, is for a "Large Scale Antibody and T Cell Epitope Discovery Program" with a period of performance through September 30, 2009. The contract is a cost-no-fee type, without any set-aside designation. LJI is an experienced federal contractor...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the La Jolla Institute for Immunology (LJII), a non-profit research institute. The contract, valued at $52,963,056.00, is for the "IMMUNE EPITOPE DATABASE AND ANALYSIS PROGRAM" and does not have a set-aside designation. The contract is a definitive contract with a cost-no-fee pricing type, with a period of performance ending on...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $4,188,056.00 definitive cost-type contract to the Scripps Research Institute, a renowned nonprofit biomedical research organization, for a Large Scale Antibody and T Cell Epitope Discovery Program. This contract, which did not utilize any set-aside designations, is focused on advancing the development of novel vaccine candidates and therapeutics for infectious diseases. Scripps, which often serves as both a prime...
- The National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) awarded a $5,455,891.00 definitive contract to the La Jolla Institute for Immunology (LJI), a non-profit research institute, to conduct research on the identification and characterization of T cell epitopes from bacterial pathogens causing pneumonia. The contract, which is not set-aside, has a completion date of September 29, 2029. LJI will perform specialized research services to support...
- This is a $5,820,000 cost-no-fee, definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) to the University of Massachusetts Medical School (UMass Medical) to support research on T cell immune epitopes associated with infectious diseases, autoimmune diseases, commensal organisms, and transplant rejection. The contract, which runs through September 29, 2029, is an outgrowth of a pre-solicitation notice NIAID...
- This firm fixed-price purchase order contract, valued at $75,848.00, was awarded by the Bureau of Medicine and Surgery, a defense agency, to the La Jolla Institute for Immunology, a non-profit research institute. The contract has two main tasks: 1) Predicting MHC class I and II epitopes for 400 prioritized Plasmodium falciparum proteins based on HLA data from 28 research subjects, and 2) Predicting MHC class I and II epitopes within the three NAVOX vaccine antigens (CSP, AMA1, and TRAP) based on...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the La Jolla Institute for Immunology, a non-profit research institute. The $5,982,815.17 definitive contract is for biomedical research services, with a period of performance from September 30, 2009 to September 29, 2014. The contract did not have a set-aside designation. The La Jolla Institute for Immunology, which conducts...